Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
48%
ALSO IN WDNA
WDNA
85
HOLDINGS
30%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.3% | 3.0% | 3.0% |
|
PFIZER INC | 3.7% | 2.5% | 2.5% |
|
ELI LILLY & CO | 6.8% | 2.4% | 2.4% |
|
UNITED THERAPEUTICS CORP | 3.2% | 2.4% | 2.4% |
|
AMGEN INC | 3.5% | 2.3% | 2.3% |
FTXH Overweight Relative to WDNA
|
ABBVIE INC | 6.8% |
|
MERCK & CO. INC. | 6.7% |
|
BRISTOL-MYERS SQUIBB CO | 6.1% |
|
ELI LILLY & CO | 4.4% |
|
JOHNSON & JOHNSON | 4.4% |
|
CARDINAL HEALTH INC | 3.6% |
|
VIATRIS, INC. | 3.4% |
|
ZOETIS INC | 2.8% |
|
BIOGEN IDEC INC | 2.7% |
|
REGENERON PHARMACEUTICALS | 2.6% |
FTXH Underweight Relative to WDNA
|
EXACT SCIENCES CORP | -28.0% |
|
MODERNA, INC. | -3.8% |
|
STOKE THERAPEUTICS, INC. | -2.5% |
|
NATERA INC | -2.2% |
 |
ASTRAZENECA PLC | -2.1% |
|
AMICUS THERAPEUTICS INC | -2.1% |
 |
BIONTECH SE SPONSORED ADR | -1.9% |
 |
NOVOZYMES A/S-B SHARES | -1.8% |
|
CRISPR THERAPEUTICS AG | -1.7% |
|
BEAM THERAPEUTICS, INC. | -1.6% |